RUSSELL FRANK CO/ - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 120 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2015. The put-call ratio across all filers is 3.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
RUSSELL FRANK CO/ ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2015$79,000
+132.4%
27,998
+160.2%
0.00%
Q3 2015$34,000
-64.6%
10,760
-33.3%
0.00%
Q2 2015$96,000
+3100.0%
16,140
+6597.1%
0.00%
Q1 2015$3,000
-99.8%
241
-99.9%
0.00%
-100.0%
Q4 2014$1,768,000
+167.9%
187,672
+118.5%
0.00%
+200.0%
Q3 2014$660,000
-19.3%
85,893
-21.0%
0.00%0.0%
Q2 2014$818,000
+5742.9%
108,749
+2047.9%
0.00%
Q3 2013$14,0005,063
+8941.1%
0.00%
Q2 2013$0560.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q1 2015
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 4,800,000$15,168,0005.18%
Avoro Capital Advisors LLC 6,004,564$18,974,0004.93%
DG Capital Management, LLC 695,808$2,199,0002.56%
ACUTA CAPITAL PARTNERS, LLC 1,108,719$3,504,0002.03%
Aisling Capital LLC 2,010,000$6,352,0001.12%
Broadfin Capital, LLC 6,090,829$19,247,0001.07%
KOPP INVESTMENT ADVISORS LLC 375,293$1,186,0000.64%
SEARLE & CO. 172,500$545,0000.56%
Elk Creek Partners, LLC 1,864,515$5,892,0000.48%
WALL STREET ASSOCIATES 696,300$2,200,0000.42%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders